Supply of Infliximab for subcutaneous administration
Supply of Infliximab for subcutaneous administration: continuous supply of the medicinal product Infliximab (ATC L04AB02) in dosage forms 120MG INJ SOL PEP (unit 2X1ML) and 120MG INJ SOL ISP (unit 2X1ML), total quantity 4,000 units.
CONTRACTING AUTHORITY
Name
Fakultní Thomayerova nemocnice
City
Praha
Country
CZ
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33652300, Immunosuppressive agents.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
33 days remaining(LOT-0001)
Published